The HEP-OKS Study - Hemifield Eye Patching and Optokinetic Stimulation to Treat Hemispatial Neglect in Stroke Patients
The HEP-OKS Pilot Study - a Randomized Controlled Trial of Hemifield Eye Patching and Optokinetic Stimulation to Treat Hemispatial Neglect in Stroke Patients
1 other identifier
interventional
23
1 country
1
Brief Summary
Spatial neglect represents one of the major cognitive disorders following stroke. Patients patients fail to be aware of objects or people to their left and orientate instead to their right side. Enduring neglect has been found to be a poor prognostic indicator for functional independence following stroke. Despite some promising experimental accounts there are no established treatments for this condition. The aim of this study is to test whether a combined treatment with hemifield eye patching (HEP) and optokinetic stimulation (OKS) can permanently reduce neglect behaviour and improve functional outcome in patients with hemispatial neglect following stroke. The investigators hypothesise that the treatment with HEP and OKS will lead to a greater reduction of neglect scoring in the neglect test battery as well as a greater improvement in functional independence scores as compared to the spontaneous clinical course of the usual-care control group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Aug 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 5, 2012
CompletedFirst Posted
Study publicly available on registry
June 12, 2012
CompletedStudy Start
First participant enrolled
August 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2014
CompletedApril 8, 2014
April 1, 2014
1.5 years
June 5, 2012
April 7, 2014
Conditions
Outcome Measures
Primary Outcomes (2)
Total score in a neglect test battery
Performance in a neglect test battery (score between 0 and 100%) consisting of standard neglect tests including two cancellation tasks, line bisection, figure copying and text reading
Change from baseline at Day 8 (post-treatment)
Functional independence score
Level of functional independence (score between 0 and 100%) as measured by the Barthel-Index and the Catherine-Bergego-Scale
Change from baseline at Day 8 (post-treatment)
Secondary Outcomes (5)
Performance in paper-and-pencil subtests
Change from baseline at Day 8 and at Day 30
Performance in computerized attention tests
Change from baseline at Day 8 and at Day 30
MRI
Day 1
Total score in the neglect test battery at follow-up
Change from baseline at Day 30
Functional independence score at follow-up
Change from baseline at Day 30
Study Arms (2)
Usual care
NO INTERVENTIONPatients in this control group will receive usual care following stroke including standard physiotherapy and occupational therapy.
HEP-OKS
EXPERIMENTALInterventions
Patients in this arm will wear standard spectacle frames containing noncorrective lenses to which right half-field patches are attached (hemifield eye patching, HEP). In case of patients already wearing prescribed glasses, the patches will be attached to their own glasses. The glasses will be worn all-day for the duration of the treatment phase (seven days) and only be removed for sleeping and face cleaning as well as for the duration of the daily OKS treatment sessions. Furthermore these patients will receive daily sessions (20 minutes) of optokinetic stimulation (OKS). Therefore patients will be seated in front of a widescreen monitor, watching a black background with a pattern of various objects (size 1°), which coherently and continuously move to the left at a velocity of 10 °/s.
Eligibility Criteria
You may qualify if:
- Right hemisphere stroke
- Spatial neglect as determined by pathological scores in at least two tests of a neglect test battery (Azouvi et al., JNNP, 2004)
- Age \> 18 years old
- Informed consent signature
You may not qualify if:
- Bilateral or previous unilateral stroke lesions
- Pre-existing neurodegenerative disease
- Inability to give informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Luebecklead
- German Research Foundationcollaborator
Study Sites (1)
University of Luebeck, Dept. of Neurology
Lübeck, Schleswig-Holstein, 23538, Germany
Related Publications (1)
Machner B, Konemund I, Sprenger A, von der Gablentz J, Helmchen C. Randomized controlled trial on hemifield eye patching and optokinetic stimulation in acute spatial neglect. Stroke. 2014 Aug;45(8):2465-8. doi: 10.1161/STROKEAHA.114.006059. Epub 2014 Jun 12.
PMID: 24923723DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bjoern Machner, MD
University of Luebeck
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, Principal Investigator
Study Record Dates
First Submitted
June 5, 2012
First Posted
June 12, 2012
Study Start
August 1, 2012
Primary Completion
February 1, 2014
Study Completion
February 1, 2014
Last Updated
April 8, 2014
Record last verified: 2014-04